Suppr超能文献

来自[具体来源未给出]的多肽组分在淀粉样β寡聚体诱导的阿尔茨海默病模型中的抗炎活性

Anti-inflammatory Activity of a Polypeptide Fraction From in Amyloid β Oligomers Induced Model of Alzheimer's Disease.

作者信息

Ge Xiangyu, Wang Yitong, Yu Shu, Cao Xuemin, Chen Yicong, Cheng Qiong, Ding Fei

机构信息

Key Laboratory of Neuroregeneration of Jiangsu and Ministry of Education, Jiangsu Province Co-innovation Center of Neuroregeneration, NMPA Key Laboratory for Research and Evaluation of Tissue Engineering Technology Products, Nantong University, Nantong, China.

School of Medicine, Nantong University, Nantong, China.

出版信息

Front Pharmacol. 2021 Aug 12;12:716177. doi: 10.3389/fphar.2021.716177. eCollection 2021.

Abstract

Neuroinflammation plays a crucial role in neurodegenerative diseases such as Alzheimer's disease (AD) and Parkinson's disease (PD), and anti-inflammation has been considered as a potential therapeutic strategy. polypeptide fraction k (ABPPk) was shown to protect neurons from death and suppress microglia and astrocyte activation in PD model mice. However, how ABPPk regulates neuroinflammation to exert a neuroprotective role remains unclear. Toxic Aβ oligomers (AβOs) can trigger inflammatory response and play an important role in the pathogenesis of AD. In the present study, for the first time, we investigated the effects and underlying mechanisms of ABPPk on neuroinflammation in AβOs-induced models of AD. , ABPPk pretreatment dose-dependently inhibited AβOs-induced pro-inflammatory cytokines mRNA levels in BV2 and primary microglia. ABPPk pretreatment also reduced the neurotoxicity of BV2 microglia-conditioned media on primary hippocampal neurons. Furthermore, ABPPk down-regulated the AβOs-induced phosphorylation of IκBα and NF-κB p65 as well as the expression of NLRP3 in BV2 microglia. , ABPPk pre-administration significantly improved locomotor activity, alleviated memory deficits, and rescued neuronal degeneration and loss in the hippocampus of AβOs-injected mice. ABPPk inhibited the activation of microglia in hippocampal CA3 region and suppressed the activation of NF-κB as well as the expression of NLRP3, cleaved caspase-1, and ASC in the brain after AβOs injection. ABPPk hindered the release of pro-inflammatory cytokines and promoted the release of anti-inflammatory cytokines in the brain. Notably, the polarization experiment on BV2 microglia demonstrated that ABPPk inhibited M1-phenotype polarization and promoted M2-phenotype polarization by activating the LPS- or AβOs-impaired autophagy in microglia. Taken together, our observations indicate that ABPPk can restore the autophagy of microglia damaged by AβOs, thereby promoting M2-phenotype polarization and inhibiting M1-phenotype polarization, thus playing a role in regulating neuroinflammation and alleviating neurotoxicity.

摘要

神经炎症在阿尔茨海默病(AD)和帕金森病(PD)等神经退行性疾病中起着关键作用,抗炎已被视为一种潜在的治疗策略。研究表明,多肽组分k(ABPPk)可保护神经元免于死亡,并抑制帕金森病模型小鼠中的小胶质细胞和星形胶质细胞激活。然而,ABPPk如何调节神经炎症以发挥神经保护作用仍不清楚。有毒的Aβ寡聚体(AβOs)可引发炎症反应,并在AD的发病机制中起重要作用。在本研究中,我们首次研究了ABPPk对AβOs诱导的AD模型中神经炎症的影响及潜在机制。ABPPk预处理以剂量依赖的方式抑制了BV2细胞和原代小胶质细胞中AβOs诱导的促炎细胞因子mRNA水平。ABPPk预处理还降低了BV2小胶质细胞条件培养基对原代海马神经元的神经毒性。此外,ABPPk下调了AβOs诱导的BV2小胶质细胞中IκBα和NF-κB p65的磷酸化以及NLRP3的表达。ABPPk预先给药显著改善了AβOs注射小鼠的运动活性,减轻了记忆缺陷,并挽救了海马中的神经元变性和损失。ABPPk抑制了海马CA3区小胶质细胞的激活,并抑制了AβOs注射后脑中NF-κB的激活以及NLRP3、裂解的半胱天冬酶-1和ASC的表达。ABPPk阻碍了脑中促炎细胞因子的释放,并促进了抗炎细胞因子的释放。值得注意的是,对BV2小胶质细胞的极化实验表明,ABPPk通过激活小胶质细胞中LPS或AβOs损伤的自噬来抑制M1表型极化并促进M2表型极化。综上所述,我们的观察结果表明ABPPk可以恢复被AβOs损伤的小胶质细胞的自噬,从而促进M2表型极化并抑制M1表型极化,进而在调节神经炎症和减轻神经毒性中发挥作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9876/8397449/002322b25187/fphar-12-716177-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验